Back to search
FDAFDA · Food and drugs·Recall number D-1255-2016

DULOXETINE Delayed-Release Capsules, USP, 60 mg, 1000 count bottles, Rx only, Manufactured by: Laboratorios del Dr. Esteve, SA, Martorelles, Barcelona --- NDC 60429-166-10

Published July 20, 2016 · Recall initiated: June 28, 2016

Summary

FDA records drug Class III recall D-1255-2016, published July 20, 2016 and initiated June 28, 2016. Recalling firm: Golden State Medical Supply Inc.; Status: Terminated; Reported quantity: 2077 bottles; Lot: Lot# GS011709, GS012352. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling; Incorrect or Missing Lot and/or Exp Date; incorrect expiration date on container label is 02/2019, correct expiration date should be 02/2018

What to do

Voluntary: Firm initiated · Letter

Get an email if DULOXETINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DULOXETINE
Manufacturer
Golden State Medical Supply Inc.
Distributor
Nationwide. No foreign distribution.
Lot
Lot# GS011709, GS012352
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was DULOXETINE Delayed-Release Capsules, USP, 60 mg, 1000 count bottles, Rx only, Manufactured by: Laboratorios del Dr. Esteve, SA, Martorelles, Barcelona --- NDC 60429-166-10 recalled?

Yes. FDA published recall D-1255-2016 on July 20, 2016. Reported hazard: Labeling; Incorrect or Missing Lot and/or Exp Date; incorrect expiration date on container label is 02/2019, correct expiration date should be 02/2018

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DULOXETINE.